<DOC>
	<DOCNO>NCT00473200</DOCNO>
	<brief_summary>The purpose study investigate whether S-adenosylmethionine ( SAMe ) , natural substance available nutritional supplement , influence blood level homocysteine ( Hcy ) . More specifically , determine chronic oral SAMe administration affect homocysteine metabolism patient vascular disease mild moderate hyperhomocysteinemia .</brief_summary>
	<brief_title>Effect S-adenosylmethionine ( SAMe ) Blood Levels Homocysteine</brief_title>
	<detailed_description>The purpose study investigate whether S-adenosylmethionine ( SAMe ) , natural substance available nutritional supplement , influence blood level homocysteine ( Hcy ) . More specifically , determine chronic oral SAMe administration effect homocysteine metabolism patient vascular disease mild moderate hyperhomocysteinemia follow specific aim : Specific Aim 1 - To determine effect oral SAMe ( 1200 mg/day ) plasma total homocysteine level subject mild moderate hyperhomocysteinemia . Specific Aim 2 - To determine effect oral SAMe ( 1200 mg/day ) without supplementation folate , vitamin B12 B6 , plasma homocysteine level patient mild moderate hyperhomocysteinemia . Specific Aim 3 - To determine effect oral SAMe ( 1200 mg/day ) plasma level pf asymmetric dimethylarginine ( ADMA ) subject mild moderate hyperhomocysteinemia .</detailed_description>
	<mesh_term>Hyperhomocysteinemia</mesh_term>
	<criteria>18 year age old Must serum homocysteine value great equal 14 Î¼mol/L Stable weight 3 month prior study participation Subjects BMI great 35 less 18 Currently take B 100 highdose B vitamin supplement within past 12 month Taken methionine SAMe supplement within past 3 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>hyperhomocysteinemia</keyword>
	<keyword>homocysteine</keyword>
	<keyword>S-adenosylmethionine</keyword>
	<keyword>SAMe</keyword>
	<keyword>Asymmetric dimethylagrinine ( ADMA )</keyword>
</DOC>